Axitan, a biotech company specializing in the development of endolysin enzyme products to replace antibiotics in animal feed, has recently announced a strategic partnership with QualiTech, a global manufacturer of animal nutrition, plant nutrition, and food ingredient products and services. This partnership aims to develop and distribute new endolysin products for the poultry, swine, and ruminant industries.
The CEO of Axitan, Alfred Zimmerman, expressed excitement about this collaboration, highlighting the potential for endolysins to revolutionize antibiotic-free production in animal agriculture. He emphasized the significance of this agreement with QualiTech in advancing their shared goal of providing innovative solutions for the industry.
As part of the partnership agreement, QualiTech will serve as the exclusive distributor for Axitan’s FORC3® product in the swine, ruminant, and poultry markets in North America, with the exception of broilers. FORC3® has demonstrated exceptional efficacy in targeting Clostridium perfringens, the causative agent of necrotic enteritis in poultry, making it a valuable solution for improving animal health and productivity.
In addition to distributing FORC3®, Axitan and QualiTech are collaborating on the development of new endolysin-based products tailored to address pathogenic challenges in the swine and ruminant segments. QualiTech will have exclusive distribution rights for these products in the swine and ruminant markets in North America, further expanding their portfolio of innovative animal nutrition solutions.
Alfred Zimmerman reiterated the potential of endolysins in driving the next generation of antibiotic-free production and expressed confidence in the partnership with QualiTech to leverage their expertise and market presence. Axitan’s dedicated biotech team has been at the forefront of incorporating endolysins into animal feed to target and eliminate pathogens traditionally managed through antibiotics, with a focus on providing tangible benefits to livestock farmers while mitigating pathogen-related risks.
Endolysins stand out for their specific targeting of pathogens and their ability to avoid triggering antimicrobial resistance, making them a promising alternative to conventional antibiotics. Axitan’s flagship product, FORC3®, has already demonstrated its efficacy in poultry production by effectively combating Clostridium perfringens, with a robust pipeline of new endolysin-based products in development to address other pathogenic challenges in the industry.
Scott Hine, President of QualiTech’s Animal Nutrition and Agronomy businesses, expressed enthusiasm about the synergies between Axitan’s product line and QualiTech’s existing solutions, underscoring the shared commitment to promoting animal health and performance. The collaboration between the two companies aligns with the growing consumer demand for antibiotic-free, high-protein food sources, positioning them as leaders in delivering quality ingredients and nutrients that support animal wellbeing.
In conclusion, the strategic partnership between Axitan and QualiTech represents a significant step forward in advancing the development and distribution of innovative endolysin products for the poultry, swine, and ruminant industries. By combining their respective expertise and resources, the two companies are poised to drive positive change in animal agriculture and meet the evolving needs of the market.
